THOMAS PETER GRACE JR
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- FINDLAY, OH
- NPI
- 1295047298
- Received
- $520,346 in 730 records, 2019 to 2025 ($503,108 general, $17,238 research)
- As principal investigator
- $819,591 of research payments to others in 15 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 97 | $79,477 |
| 2024 | General payment | 74 | $40,692 |
| 2023 | General payment | 171 | $129,608 |
| 2022 | General payment | 192 | $140,462 |
| 2022 | Research payment | 1 | $17,238 |
| 2021 | General payment | 116 | $86,949 |
| 2020 | General payment | 52 | $24,226 |
| 2019 | General payment | 27 | $1,691 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Dexcom, Inc. | 240 | $233,925 | 2020–2025 |
| Lilly USA, LLC | 252 | $164,403 | 2019–2025 |
| Novo Nordisk Inc | 181 | $105,069 | 2019–2024 |
| SANOFI-AVENTIS U.S. LLC | 27 | $9,843 | 2019–2023 |
| Insulet Corporation | 8 | $3,321 | 2019–2023 |
| Eli Lilly and Company | 1 | $1,875 | 2022 |
| Tandem Diabetes Care, Inc. | 5 | $1,256 | 2019–2024 |
| Abbott Laboratories | 11 | $380 | 2019–2023 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 | 2023 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $117 | 2022 |
| Janssen Pharmaceuticals, Inc | 1 | $18 | 2019 |
| AstraZeneca Pharmaceuticals LP | 1 | $11 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 248 | $294,605 |
| Compensation for serving as faculty or as a speaker for a medical education program | 45 | $134,784 |
| Travel and Lodging | 158 | $34,143 |
| Consulting Fee | 14 | $27,052 |
| Research payment | 1 | $17,238 |
| Food and Beverage | 261 | $11,074 |
| Honoraria | 1 | $1,400 |
| Education | 2 | $48 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | Lilly USA, LLC | $126 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-25 | Lilly USA, LLC | $57 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-24 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-18 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-13 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-12 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-12 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-11-07 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-31 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-31 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-31 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-30 | Lilly USA, LLC | $70 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-29 | Lilly USA, LLC | $124 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-27 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-27 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-21 | Dexcom, Inc. | $157 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-10-09 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-10-03 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-09-29 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-31 | Lilly USA, LLC | $154 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-29 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-09 | Lilly USA, LLC | $152 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-09 | Lilly USA, LLC | $81 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-01 | Lilly USA, LLC | $90 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-07-01 | Lilly USA, LLC | $81 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-30 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-27 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-24 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-24 | Lilly USA, LLC | $83 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-24 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-24 | Lilly USA, LLC | $5 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-23 | Lilly USA, LLC | $105 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-20 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-20 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-06-04 | Lilly USA, LLC | $79 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-30 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-29 | Lilly USA, LLC | $5 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-27 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-27 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-23 | Lilly USA, LLC | $675 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-19 | Lilly USA, LLC | $58 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $63 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-16 | Lilly USA, LLC | $49 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-14 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-14 | Lilly USA, LLC | $675 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-13 | Lilly USA, LLC | $109 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $211 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $13 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-12 | Lilly USA, LLC | $4 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-09 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-07 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-06 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-02 | Lilly USA, LLC | $74 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-01 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-01 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-29 | Lilly USA, LLC | $126 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-18 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-16 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-15 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-11 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-10 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-07 | Lilly USA, LLC | $78 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-04 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-04 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-26 | Lilly USA, LLC | $3 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-25 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-24 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-19 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-17 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-14 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-14 | Lilly USA, LLC | $675 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-14 | Lilly USA, LLC | $47 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Lilly USA, LLC | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Lilly USA, LLC | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Lilly USA, LLC | $140 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Lilly USA, LLC | $64 | Travel and Lodging | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-12 | Lilly USA, LLC | $13 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-10 | Lilly USA, LLC | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-03 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-02-05 | Lilly USA, LLC | $3,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-31 | Lilly USA, LLC | $522 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-01-31 | Lilly USA, LLC | $33 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-01-29 | Dexcom, Inc. | $120 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2025-01-28 | Dexcom, Inc. | $127 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2025 | |
| 2024-12-13 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-12-12 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-12-10 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-11-27 | Lilly USA, LLC | $375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-10-02 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-10-02 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-25 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-20 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-19 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-17 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-16 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-12 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-09-06 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-30 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-26 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-22 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-21 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-08-04 | Dexcom, Inc. | $35 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-07-02 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-22 | Tandem Diabetes Care, Inc. | $116 | Food and Beverage | In-kind items and services | t:slim X2 Insulin Pump with Control-IQ Device, Endocrinology | 2024 | |
| 2024-06-14 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-06-11 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-29 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-24 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-22 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-20 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-14 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-10 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-09 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-06 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-02 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-05-02 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-04-25 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-04-24 | Dexcom, Inc. | $21 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-04-16 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-04-12 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-04-02 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-04-01 | Novo Nordisk Inc | $1,595 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Ozempic Drug, Diabetes | 2024 | |
| 2024-03-28 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-03-05 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-03-04 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-03-01 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-29 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-27 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-15 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-15 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-12 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-06 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-02-01 | Dexcom, Inc. | $90 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-01-29 | Lilly USA, LLC | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2024 | |
| 2024-01-12 | Lilly USA, LLC | $134 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-01-12 | Lilly USA, LLC | $108 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-01-12 | Lilly USA, LLC | $60 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-01-12 | Lilly USA, LLC | $35 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-01-12 | Lilly USA, LLC | $18 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-01-12 | Lilly USA, LLC | $6 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-01-11 | Dexcom, Inc. | $13 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2024 | |
| 2024-01-10 | Lilly USA, LLC | $3,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $373 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $245 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $175 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $139 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $101 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $59 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $44 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $39 | Education | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $34 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $33 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $8 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $4 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-04 | Lilly USA, LLC | $1 | Food and Beverage | In-kind items and services | 2024 | ||
| 2023-12-12 | Dexcom, Inc. | $13 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-12-05 | Dexcom, Inc. | $5,163 | Consulting Fee | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-11-29 | Dexcom, Inc. | $4 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-11-01 | Dexcom, Inc. | $163 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-10-30 | Dexcom, Inc. | $3 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2023 | |
| 2023-10-24 | Dexcom, Inc. | $160 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-10-10 | Dexcom, Inc. | $121 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-09-15 | Dexcom, Inc. | $263 | Travel and Lodging | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-09-15 | Dexcom, Inc. | $213 | Travel and Lodging | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-09-15 | Dexcom, Inc. | $29 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2023 | |
| 2023-09-14 | Dexcom, Inc. | $260 | Travel and Lodging | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-09-12 | Dexcom, Inc. | $37 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-31 | Dexcom, Inc. | $131 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-31 | Dexcom, Inc. | $56 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-31 | Dexcom, Inc. | $10 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-30 | Dexcom, Inc. | $177 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-30 | Dexcom, Inc. | $140 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-30 | Dexcom, Inc. | $62 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-28 | SANOFI-AVENTIS U.S. LLC | $26 | Food and Beverage | In-kind items and services | TZIELD Biological, Endocrine & Metabolic Diseases | 2023 | |
| 2023-08-25 | Dexcom, Inc. | $260 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-25 | Dexcom, Inc. | $131 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-25 | Dexcom, Inc. | $74 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-25 | Dexcom, Inc. | $39 | Food and Beverage | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-24 | Dexcom, Inc. | $4,149 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-24 | Dexcom, Inc. | $982 | Travel and Lodging | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-22 | Dexcom, Inc. | $303 | Travel and Lodging | In-kind items and services | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-22 | Dexcom, Inc. | $94 | Food and Beverage | In-kind items and services | Dexcom G6 Transmitter Medical Supply, Endocrinology | 2023 | |
| 2023-08-17 | Dexcom, Inc. | $544 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 | |
| 2023-08-17 | Dexcom, Inc. | $157 | Travel and Lodging | Cash or cash equivalent | DEXCOM G7 GSS (161) Medical Supply, Endocrinology | 2023 |
The latest 200 records of 730.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-01-02 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $110,880 | COMMUNITY GLUCOSE MONITORING PROJECT | 2025 |
| 2024-03-12 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $2,393 | COMMUNITY GLUCOSE MONITORING PROJECT | 2024 |
| 2024-01-03 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $323,910 | COMMUNITY GLUCOSE MONITORING PROJECT | 2024 |
| 2023-03-07 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $2,145 | COMMUNITY GLUCOSE MONITORING PROJECT | 2023 |
| 2023-02-23 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $198,180 | COMMUNITY GLUCOSE MONITORING PROJECT | 2023 |
| 2023-02-23 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $15,268 | COMMUNITY GLUCOSE MONITORING PROJECT | 2023 |
| 2023-01-11 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $69,706 | COMMUNITY GLUCOSE MONITORING PROJECT | 2023 |
| 2023-01-11 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $13,565 | COMMUNITY GLUCOSE MONITORING PROJECT | 2023 |
| 2022-05-27 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $3,161 | COMMUNITY GLUCOSE MONITORING PROJECT | 2022 |
| 2022-05-27 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $85 | COMMUNITY GLUCOSE MONITORING PROJECT | 2022 |
| 2022-05-27 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $55,634 | COMMUNITY GLUCOSE MONITORING PROJECT | 2022 |
| 2022-05-27 | Dexcom, Inc. | Blanchard Valley Diabetes Center | $79 | COMMUNITY GLUCOSE MONITORING PROJECT | 2022 |
| 2020-03-05 | Dexcom, Inc. | BLANCHARD VALLEY | $2,311 | EFFECTS OF CONTINUOUS GLUCOSE MONITORING IN TYPE 2 DIABETICS WHO DO NOT QUALIFY FOR INSURANCE COVERAGE OF CONTINUOUS GLU | 2020 |
| 2020-03-05 | Dexcom, Inc. | BLANCHARD VALLEY | $16,707 | EFFECTS OF CONTINUOUS GLUCOSE MONITORING IN TYPE 2 DIABETICS WHO DO NOT QUALIFY FOR INSURANCE COVERAGE OF CONTINUOUS GLU | 2020 |
| 2020-03-05 | Dexcom, Inc. | BLANCHARD VALLEY | $5,563 | EFFECTS OF CONTINUOUS GLUCOSE MONITORING IN TYPE 2 DIABETICS WHO DO NOT QUALIFY FOR INSURANCE COVERAGE OF CONTINUOUS GLU | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Findlay, OH, county Hancock County, OH, state Ohio; placed by its city name.
| Measure | Place (city or town) Findlay, OH | County Hancock County, OH | State Ohio |
|---|---|---|---|
| Population B01003 | 40,287 | 74,866 | 11,810,293 |
| Population, 2020 census P1 | 40,313 | 74,920 | 11,799,448 |
| Median age B01002 | 38.0 | 39.5 | 39.7 |
| Under 18 B01001 | 19.9% | 21.8% | 22.0% |
| 65 and over B01001 | 19.2% | 18.6% | 18.3% |
| Households B11001 | 17,986 | 31,615 | 4,863,191 |
| Foreign born B05002 | 4.3% | 3.3% | 5.2% |
| Median household income B19013 | $61,423 | $73,141 | $71,389 |
| Median family income B19113 | $82,878 | $91,870 | $92,749 |
| Per capita income B19301 | $37,029 | $39,068 | $40,552 |
| Poverty rate B17001 | 12.3% | 9.9% | 13.3% |
| Unemployment rate B23025 | 3.5% | 3.1% | 4.8% |
| Civilian labor force B23025 | 20,835 | 38,730 | 5,994,779 |
| Mean commute (minutes) B08013 | 16.1 | 18.0 | 23.4 |
| Bachelor's degree or higher B15003 | 30.6% | 30.3% | 31.5% |
| Housing units B25001 | 19,200 | 33,920 | 5,292,391 |
| Owner-occupied B25003 | 59.9% | 70.8% | 67.2% |
| Renters B25003 | 40.1% | 29.2% | 32.8% |
| Median home value B25077 | $191,000 | $204,700 | $214,800 |
| Median gross rent B25064 | $975 | $979 | $1,034 |
| White, not Hispanic B03002 | 82.8% | 86.9% | 75.8% |
| Black B03002 | 2.6% | 1.8% | 12.0% |
| Hispanic or Latino B03002 | 8.5% | 6.1% | 4.8% |
| Asian B03002 | 2.2% | 1.9% | 2.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Findlay, OH.
Comments